Lv3
280 积分 2024-12-16 加入
Combination of Anti-CD19 and Anti-CD20 Chimeric Antigen Receptor T Cells for Relapsed and Refractory Diffuse Larger B Cell Lymphoma: An Open-Label, Single-Arm, Phase Ⅰ/Ⅱ Trial
2个月前
已关闭
Golcadomide: An Oral CELMoD Agent Targeting IKZF1/3 for Diffuse Large B-cell Lymphoma
2个月前
已完结
The Promise and Challenges of CAR-T Gene Therapy
3个月前
已完结
Tragedy, Perseverance, and Chance — The Story of CAR-T Therapy
3个月前
已完结
A Multicenter Study on Front-Line Treatment of Diffuse Large B-Cell Lymphoma with Zanubrutinib Combination Therapy
3个月前
已关闭
A Multicenter Study on Front-Line Treatment of Diffuse Large B-Cell Lymphoma with Zanubrutinib Combination Therapy
3个月前
已关闭
Bispecific antibody combination regimens for B-cell non-Hodgkin’s lymphomas
3个月前
已完结
Bispecific antibody combination regimens for B-cell non-Hodgkin's lymphomas
3个月前
已关闭
皖公网安备34019202002308
